Programmed cell death in heart failure: Review;

dc.authorscopusid6602894847
dc.authorscopusid6701373149
dc.authorscopusid7102665889
dc.contributor.authorSüsleyici Duman,B.
dc.contributor.authorTürkoǧlu,Ç.
dc.contributor.authorÖztürk,M.
dc.date.accessioned2024-10-15T19:41:15Z
dc.date.available2024-10-15T19:41:15Z
dc.date.issued2005
dc.departmentKadir Has Universityen_US
dc.department-tempSüsleyici Duman B., Tibbi Biyoloji ve Genetik AD, Kadir Has Üniversitesi, Tip Fakültesi, Istanbul, Turkey, Kadir Has Üniversitesi, Tip Fakültesi, Tibbi Biyoloji ve Genetik AD, Gayrettepe, Istanbul, Vefa Bey Sok. No:5 80810, Turkey; Türkoǧlu Ç., Kardiyoloji AD, Kadir Has Üniversitesi, Tip Fakültesi, Istanbul, Turkey; Öztürk M., Tibbi Biyoloji AD, Istanbul Universitesi Cerrahpasa, Tip Fakültesi, Istanbul, Turkeyen_US
dc.description.abstractThe molecular and biochemical mechanisms of programmed cell death, also known as apoptosis, have not yet to be fully elucidated. Apoptosis is characterized by active intracellular communication, loss of cellular attachment, cell shrinkage, DNA fragmentation and phagocytosis. Recently accumulated evidence indicates that apoptosis is involved in both physiological and pathophysiological processes of heart failure. Many factors have been identified that induce cardiomyocyte apoptosis during heart failure. However, many questions remain to be answered regarding the pathophysiological triggers of apoptosis and their mechanisms. As such, due to the incipient state of research regarding the question as to whether apoptotic inhibition delays or prevents heart failure, it appears advanced molecular and pharmaco-genomic studies will be essential in identifying potential targets in prospective therapies for the prevention of apoptosis. Copyright © 2005 by Türkiye Klinikleri.en_US
dc.identifier.citation0
dc.identifier.doi[SCOPUS-DOI-BELIRLENECEK-62]
dc.identifier.endpage92en_US
dc.identifier.issn1300-0292
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-14644436361
dc.identifier.scopusqualityQ4
dc.identifier.startpage85en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12469/6423
dc.identifier.volume25en_US
dc.language.isotren_US
dc.publisherTurkiye Kliniklerien_US
dc.relation.ispartofTurkiye Klinikleri Journal of Medical Sciencesen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectApoptosisen_US
dc.subjectHeart failureen_US
dc.titleProgrammed cell death in heart failure: Review;en_US
dc.title.alternativeProgramli hücre ölümünün kalp yetersizliǧ indeki yerien_US
dc.typeReviewen_US
dspace.entity.typePublication

Files